Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-026342
Filing Date
2021-06-28
Accepted
2021-06-28 20:00:45
Documents
1
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4035
  Complete submission text file 0000899243-21-026342.txt   5724
Mailing Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Issuer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 (650) 843-5000
Carlo Rizzuto (Reporting) CIK: 0001817033 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 211055222